文献速递运动医学关节外科

前交叉韧带重建术后软骨代谢与基质重塑的系统性生物标志物:一项前瞻性研究

Systemic Biomarkers of Chondral Metabolism and Matrix Remodeling After Anterior Cruciate Ligament Reconstruction: A Prospective Study.
PubMed 文献 · Am J Sports Med · 2025-10-07

从前瞻性纵向研究中纳入666例首次前交叉韧带重建患者,在术前及术后6、12个月检测尿CTX-II、血清PIIANP和MMP-3。尿CTX-II从基线至6个月降低25%、至12个月降低37%,血清PIIANP从基线至6个月升高40%,血清MMP-3从基线至6个月和12个月分别升高35%和44%。作者认为上述变化可能提示术后12个月内软骨修复反应和持续细胞外基质重塑。

要点

  • 尿CTX-II从基线至6个月降低25%、至12个月降低37%(P < .001)。
  • 血清PIIANP从基线至6个月升高40%(P < .001),6至12个月无显著变化。
  • 血清MMP-3从基线至6个月和12个月分别升高35%和44%(P < .001)。

核心结论

  • 尿CTX-II降低伴血清PIIANP升高可能提示前交叉韧带重建术后12个月内存在修复性软骨反应。
  • 血清MMP-3升高提示同一时期内细胞外基质重塑持续且进展。
  • 基线及12个月时3种生物标志物浓度主要与非可调控人口学因素相关。

研究设计与样本

  • 研究类型为对照实验室研究,数据来自一项纵向研究。
  • 在首次前交叉韧带重建术前及术后6、12个月采集尿和血清样本。
  • 共666例患者提供样本,平均±标准差年龄24.9±7.2岁,男性占60.5%。
  • 采用免疫分析法测定尿CTX-II、血清PIIANP和血清MMP-3浓度。
  • 数据分析采用线性混合模型和线性回归。

主要发现

  • 尿CTX-II从基线至6个月降低25%(95% CI,19%-31%),从基线至12个月降低37%(95% CI,22%-42%)(P < .001)。
  • 血清PIIANP从基线至6个月升高40%(95% CI,34%-47%)(P < .001),6至12个月无显著变化。
  • 血清MMP-3从基线至6个月升高35%(95% CI,29%-42%),从基线至12个月升高44%(95% CI,37%-52%)(P < .001)。
  • 基线时,年龄、体质指数、性别和受伤至手术时间是与生物标志物浓度相关的因素。
  • 12个月时,年龄、性别、体质指数和受伤至手术时间与生物标志物浓度相关。

临床怎么用

  • 作者认为,软骨代谢生物标志物未来可能在前交叉韧带损伤患者管理中具有预后或决策作用,可能包括预测创伤后关节炎。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anterior cruciate ligament (ACL) injuries and reconstruction are associated with alterations in chondral homeostasis and posttraumatic osteoarthritis. Biomarkers of chondral metabolism may have a role in quantitatively evaluating this phenomenon. PURPOSES: To describe changes in 3 systemic biomarkers of chondral metabolism and extracellular matrix remodeling during the first year after ACL reconstruction and to identify factors associated with biomarker concentrations at the baseline and 12-month postoperative timepoints. STUDY DESIGN: Controlled laboratory study. METHODS: From a longitudinal study, urine and serum samples were taken immediately before primary ACL reconstruction and at 6 and 12 months postoperatively. A total of 666 patients provided samples (mean ± SD age, 24.9 ± 7.2 years; 60.5% male). Immunoassays were used to measure concentrations of urinary C-terminal cross-linked telopeptide of type 2 collagen (CTX-II), a marker of type 2 collagen degradation; serum N-propeptide of collagen IIA (PIIANP), a marker of type 2 collagen synthesis; and serum matrix metalloproteinase 3 (MMP-3), a mediator of extracellular matrix remodeling. Linear mixed modeling and linear regression were used for data analysis. RESULTS: Urinary CTX-II concentrations decreased by 25% (95% CI, 19%-31%) from baseline to 6 months and by 37% (95% CI, 22%-42%) from baseline to 12 months, respectively (P < .001). Serum PIIANP increased by 40% (95% CI, 34%-47%) from baseline to 6 months (P < .001) with no significant change between 6 and 12 months. Serum MMP-3 increased by 35% (95% CI, 29%-42%) and 44% (95% CI, 37%-52%) from baseline to 6 months and from baseline to 12 months respectively (P < .001). At the baseline timepoint, age, body mass index (BMI), sex, and time from injury to surgery were factors associated with biomarker concentrations. At the 12-month timepoint, age, sex, BMI, and time from injury to surgery were associated with biomarker concentrations. CONCLUSION: Decreasing urinary CTX-II concentrations coupled with increasing serum PIIANP concentrations may suggest a reparative chondral response within the first 12 months after ACL reconstruction. Increasing serum MMP-3 concentrations suggested persistent and progressive extracellular matrix remodeling during this same period. Predominantly nonmodifiable demographic factors were associated with baseline and 12-month concentrations of the 3 biomarkers. CLINICAL RELEVANCE: Biomarkers of chondral metabolism may have future prognostic or decision-making roles in the management of patients with ACL injury. This could include predicting posttraumatic arthritis.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Batty LM, Huynh M, Webster KE, et al. Systemic Biomarkers of Chondral Metabolism and Matrix Remodeling After Anterior Cruciate Ligament Reconstruction: A Prospective Study. Am J Sports Med. 2025. PMID: 41055095. doi:10.1177/03635465251376616

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。